Suscribirse

UPDATE ON INTERVENTIONAL URORADIOLOGY - 11/09/11

Doi : 10.1016/S0094-0143(05)70405-5 
Ray B. Dyer, MD *, Dean G. Assimos, MD *, John D. Regan, MD *

Resumen

More than 40 years have passed since Goodwin et al44 reported on “percutaneous trocar (needle) nephrostomy in hydronephrosis.” After a period of relative neglect, interest in the technique was rekindled with reports of the successful creation of large-bore nephrostomy tracts for percutaneous stone extraction.82, 84, 110 As the team of urologist and interventional radiologist gained experience, percutaneous nephrostolithotomy (PNL) became the primary method of treatment for stones of the upper urinary tract, and the performance of percutaneous renal entry became an almost daily occurrence in most large medical centers. The field of interventional uroradiology was born.

Approval by the Food and Drug Administration of the first device for the performance of extracorporeal shock wave lithotripsy (ESWL) in 1984 led to rapid substitution of ESWL for PNL as the primary mode of treatment for most upper urinary tract stones. As experience was gained with ESWL, limitations of the technique were defined. It was recognized that percutaneous techniques were still necessary as primary or supplemental therapy in some patients. The experience previously gained with percutaneous techniques, coupled with technologic advances in instrumentation, continued to broaden the indications for performance of percutaneous renal entry12, 35, 105:

Indications for Percutaneous Renal Entry
Urinary diversion
Supravesical obstruction
Fistula management
Adjunct therapy for complex infections
Calculus disease
Primary therapy
Combined with ESWL
Nephroscopy and ureteroscopy
Diagnostic
Therapeutic
Ureteral intervention

At the authors' institution, which is a center for treatment of stone disease, the authors average four to six new renal entries per week, about half of which are performed for complex urinary tract stones. Urinary diversion for obstruction not related to stones accounts for about one third of the entries. Also included are many unique problems that can be managed with percutaneous techniques but in the past frequently required major surgical intervention. Familiarity with basic entry techniques allows the application of interventional uroradiologic procedures to the transplant kidney and to the bladder. Applying new technologies, such as metallic stents, to difficult management problems also appears promising.

El texto completo de este artículo está disponible en PDF.

Esquema


 Address reprint requests to Ray B. Dyer, MD Department of Radiology Bowman Gray School of Medicine of Wake Forest University Medical Center Boulevard Winston-Salem, NC 27157


© 1997  W. B. Saunders Company. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 24 - N° 3

P. 623-652 - août 1997 Regresar al número
Artículo precedente Artículo precedente
  • IMAGING OF ADRENAL MASSES
  • Melvyn Korobkin, Isaac R. Francis
| Artículo siguiente Artículo siguiente
  • SCROTAL IMAGING
  • William G. Horstman

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.